Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus

摘要

Fas/Fas ligand (FasL) and B cell-activating factor (BAFF) signalling have pivotal roles in SLE pathogenesis. We investigated the clinical associations of serum concentrations of soluble Fas (sFas) and soluble FasL (sFasL) in SLE and their relationship with BAFF.